Inovio Pharmaceuticals Inc

INO

Company Profile

  • Business description

    Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

  • Contact

    660 West Germantown Pike
    Suite 110
    Plymouth MeetingPA19462
    USA

    T: +1 267 440-4200

    E: [email protected]

    https://www.inovio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    134

Stocks News & Analysis

stocks

Looking under the hood at Robinhood

We review some of the platform's most popular stocks onĀ 11 different measures of equity-related risk.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,775.4087.401.01%
CAC 407,537.5752.09-0.69%
DAX 4023,269.0181.54-0.35%
Dow JONES (US)42,581.78374.960.89%
FTSE 1008,758.0416.61-0.19%
HKSE24,145.11455.981.92%
NASDAQ19,630.97183.560.94%
Nikkei 22538,768.23414.141.08%
NZX 50 Index12,479.9952.66-0.42%
S&P 5006,025.1757.330.96%
S&P/ASX 2008,557.6082.700.98%
SSE Composite Index3,415.4533.871.00%

Market Movers